Search Results 61-70 of 16365 for SARS-CoV-2
Gregory Poland, director of Mayo Clinic's Vaccine Research Group. The virus has been named SARS-CoV-2, and the disease it causes has been named COVID-19. The ...
... COVID-19 patients with confirmed infection with the novel SARS-CoV-2 virus to enable high quality research. Participation eligibility. Participant ...
17, 2023. People with certain medical conditions. Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/ ...
The purpose of this study is to develop algorithms that will enable earlier identification and testing triggers for COVID-19 in otherwise asymptomatic patients, ...
Symptoms of COVID-19, also known as coronavirus disease 2019, can vary widely. And over time, how often people have a COVID-19 symptom may change.
Immunogenicity and Safety of Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients with Hematologic Malignancies and ...
The purpose of this study is to collect saliva specimens from individuals who tested positive for SARS-CoV-2 RNA in respiratory tract specimens to validate this ...
The purpose of this study is to determine the safety of the SARS-CoV-2 vaccination in patients listed for solid organ transplantation, including heart, lung, ...
A new virus called the 2019 novel coronavirus (2019-nCoV) has been identified as the cause of a disease outbreak that began in China. The disease is called ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.